Elyse G. Seltzer - Net Worth and Insider Trading

Elyse G. Seltzer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Elyse G. Seltzer owns 1 companies in total, including Nabriva Therapeutics PLC (NBRVF) .

Click here to see the complete history of Elyse G. Seltzer’s form 4 insider trades.

Insider Ownership Summary of Elyse G. Seltzer

Ticker Comapny Transaction Date Type of Owner
NBRVF Nabriva Therapeutics PLC 2016-12-30 Chief Medical Officer

Elyse G. Seltzer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Elyse G. Seltzer Ownership Network

Ownership Network List of Elyse G. Seltzer

No Data

Ownership Network Relation of Elyse G. Seltzer

Insider Network Chart

Elyse G. Seltzer Owned Company Details

What does Nabriva Therapeutics PLC do?

Who are the key executives at Nabriva Therapeutics PLC?

Elyse G. Seltzer is the Chief Medical Officer of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .

Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nabriva Therapeutics PLC Insider Transactions

No Available Data

Elyse G. Seltzer Mailing Address

Above is the net worth, insider trading, and ownership report for Elyse G. Seltzer. You might contact Elyse G. Seltzer via mailing address: 1000 Continental Drive, Suite 600, King Of Prussia Pa 19406.

Discussions on Elyse G. Seltzer

No discussions yet.